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Abstract
Twist1, a basic helix-loop-helix transcription factor, is expressed in mesenchymal precursor populations during
embryogenesis and in metastatic cancer cells. In the developing heart, Twist1 is highly expressed in endocardial cushion
(ECC) valve mesenchymal cells and is down regulated during valve differentiation and remodeling. Previous studies
demonstrated that Twist1 promotes cell proliferation, migration, and expression of primitive extracellular matrix (ECM)
molecules in ECC mesenchymal cells. Furthermore, Twist1 expression is induced in human pediatric and adult diseased
heart valves. However, the Twist1 downstream target genes that mediate increased cell proliferation and migration during
early heart valve development remain largely unknown. Candidate gene and global gene profiling approaches were used to
identify transcriptional targets of Twist1 during heart valve development. Candidate target genes were analyzed for
evolutionarily conserved regions (ECRs) containing E-box consensus sequences that are potential Twist1 binding sites. ECRs
containing conserved E-box sequences were identified for Twist1 responsive genes Tbx20, Cdh11, Sema3C, Rab39b, and
Gadd45a. Twist1 binding to these sequences in vivo was determined by chromatin immunoprecipitation (ChIP) assays, and
binding was detected in ECCs but not late stage remodeling valves. In addition identified Twist1 target genes are highly
expressed in ECCs and have reduced expression during heart valve remodeling in vivo, which is consistent with the
expression pattern of Twist1. Together these analyses identify multiple new genes involved in cell proliferation and
migration that are differentially expressed in the developing heart valves, are responsive to Twist1 transcriptional function,
and contain Twist1-responsive regulatory sequences.
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factor Twist1 was first identified in Drosophila as a critical regulator
of mesoderm formation and specification [1]. In mouse and avian
embryos, Twist1 functions in mesenchymal precursors of the
developing pharyngeal arches, limb, cranial sutures, and heart valve
endocardial cushions (ECC) [2–4]. Within these cell populations
Twist1 promotes cell proliferation, migration, and expression of
primitive extracellular matrix (ECM), thus promoting an undiffer-
entiated state. In humans, highly metastatic and chemotherapeutic
resistant cancers including breast, glioma, prostate, melanoma, and
neuroblastoma express high levels of TWIST1 [5]. TWIST1
expression is also upregulated in human diseased aortic valves that
have increased expression of mesenchymal markers of valve
progenitor cells [4,5]. The correlation of Twist1 expression with
increased cell proliferation and migration of cancer cells, and also in
diseased heart valves, is likely to be related to its functions in
embryonic mesenchymal populations, including ECC mesenchy-
mal cells. However, the underlying mechanisms by which Twist1
promotes proliferation and migration of mesenchymal cells during
heart valve development and disease are largely unknown.
Mesenchymal valve progenitor cells of the ECCs are highly
proliferative, migratory, and express ECM genes that encode the
relatively unstructured and open matrix of the ECCs. As heart
valve development progresses the valve progenitor cells begin to
differentiate, which is marked by decreased proliferation, de-
creased migration, and expression of genes that encode the
complex stratified ECM of the mature valves [6]. Within the
mesenchymal cell population several factors, including Twist1,
that promote cell proliferation and migration have been identified
through both in vivo and in vitro studies [4,7–10]. Previous gene
expression profiling identified Twist1 as the most differentially
expressed gene during heart valve development with preferential
expression in early ECC mesenchymal cells at embryonic day
(E)12.5 and decreased expression in remodeling valve leaflets at
E17.5 in mice [10]. In chick ECC explants, Twist1 promotes cell
proliferation and migration consistent with a role in maintaining
mesenchymal cells in an undifferentiated state [8]. There is limited
information on the Twist1 target genes that mediate increased cell
proliferation, migration, and primitive ECM gene expression.
Expression of Tbx20, Periostin, MMP13, and Cdh11 are responsive
to Twist1 expression in ECCs, but it is not known whether they
are direct or indirect transcriptional targets in the ECC
mesenchymal cells [8]. Although Twist1 regulates cell proliferation
and migration during expansion of the ECC mesenchymal cell
population, the direct molecular mechanisms by which this occurs
remain largely unknown.
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activator through binding as a homodimer or heterodimer to the
E-box DNA consensus sequence, CANNTG [11]. Twist1 forms
homodimers (Twist1-Twist1) or heterodimers with other bHLH
transcription factors, such as ubiquitously expressed E-proteins
(E12/E47) [11,12]. Previously identified Twist1 transcriptional
targets, including Periostin, N-cadherin, Collagen2a1, and Zyxin,
regulate adhesion-migration and ECM in various cell types
[4,13–15]. However, these targets do not account for all Twist1
function in ECC mesenchymal cells. Since Twist1 is highly
expressed during heart valve development and disease, identifying
the direct transcriptional targets will aid in understanding the
mechanisms through which Twist1 promotes cell proliferation,
migration, and primitive ECM gene expression.
We used a combination of approaches to identify direct
transcriptional targets of Twist1 in ECC mesenchymal cells.
Evolutionarily conserved regions (ECR) containing E-box consen-
sus sequences were identified in chicken Tbx20 and Cdh11 genes,
which were determined to be responsive to Twist1 in chick ECC
studies [8]. Additionally, microarray gene expression profiling was
performed on mouse preosteoblast cells (MC3T3-E1) transfected
with Twist1 siRNA to identify additional candidate target genes
containing ECRs. MC3T3-E1 cells express high levels of Twist1
and share significant gene expression with developing heart valves,
thus facilitating Twist1 target gene identification [10]. Differential
expression of candidate Twist1 target genes, including Sema3C,
Rab39b, and Gadd45a, in developing heart valves in a pattern
similar to Twist1 was confirmed in vivo in mice, and Twist1-
responsive regulatory elements were identified. Furthermore,
binding of Twist1 to candidate ECRs was confirmed in mouse
embryonic heart valves in vivo. Each of the identified target genes
has known functions in cell proliferation and migration, consistent
with a role in expansion of ECC mesenchymal cells during heart
valve development downstream of Twist1.
Materials and Methods
Ethics statement
All experiments with animals were carried out with experimen-
tal protocols and procedures reviewed and approved by the
Cincinnati Children’s Hospital Medical Center Biosafety Com-
mittee and Institutional Animal Care and Use Committee,
protocol numbers 9D01009 and 0B08062.
Genomic sequence analysis for ECRs
ECRs containing bHLH protein binding E-box consensus
sequences (CANNTG) were identified using a combination of
rVista2.0/ECR browser (http://rvista.dcode.org/ [16]), oPOS-
SUM (http://www.cisreg.ca/oPOSSUM/) [17], Trafac [18], and
DiRe (Distant Regulatory elements of co-regulated genes, http://
dire.dcode.org/ [19]) genome-wide analyses. ECR alignments
were generated for homologous sequences based on sequence
conservation in multiple species as identified by rVista analysis
(Figure S1, Figure S2, Figure S3, Figure S4). Tbx20boxA
(NW_001471633.1, bps 46990932 to 46991520 for luciferase
assays and NW_001030907.1, bps 18507205 to 18507355 for
ChIP) and Cdh11-Intron1 (NW_001471435.1, bps 4202820 to
4203373 for luciferase assays and NW_001030904.1, bps
30738937 to 30739030 for ChIP) ECRs were identified using
rVista2.0/ECR browser with chicken as the base genome. Sema3C-
Intron1 (NW_001030784.1, bps 1843993 to 1844225), Gadd45a-
promoter (NW_001030811.1, bps 8955961 to 8956176) and Rab39b-
39UTR (NW_001035174.1, bps 660467 to 660626) ECRs were
identified through a combination of rVista2.0/ECR browser,
Trafac, DiRE, and oPOSSUM analyses with mouse as a base
genome.
Plasmids, transfections, and dual luciferase assay
Chicken Tbx20boxA and Cdh11-Intron1 ECRs were amplified
from genomic DNA isolated from white leghorn chicken embryos
at E4.5 (Charles River, CT). 1 mg of chicken genomic DNA was
used for PCR with the following primer sets and annealing
temperatures: Tbx20boxA (59- TAC GAG GGG GCT GTG AGG
TCT -39 and 59- GCA AAG CAA GCA ATC GTG AA -39,
55uC, 32 cycles) and Cdh11-Intron1 (59- GGT TGG GGT TGT
TTA GGG TTT C -39 and 59- AGC CAT GTC TTC AGT
GTC GTT TTA -39,5 6 uC, 28 cycles). Mouse Sema3CIntron1,
Gadd45a-promoter, and Rab39b-39UTR ECRs were amplified from
mouse genomic DNA isolated from cultured MC3T3-E1 cells
(ATCC, CRL-2593) [20] with the following primer sets and
annealing temperatures: Sema3CIntron1 (59- GGA AAG TCA CCC
ATA AAA ATC AA -39 and 59- TAA ACA CAG CAT GCA
ATC TCA AA -39,5 4 uC, 35 cycles), Rab39b-39UTR (59- CTG
GAA TAT AAG ACA ATC -39 and 59-CTG CAA TAA GTG
GGT TTT -39,5 5 uC, 30 cycles), and Gadd45a-promoter (59- GCT
GAA TCA TGA AGC TGT AAC TG -39 and 59- GGT TCA
GGC AAT GCT TTT GT -39,5 5 uC, 30 cycles). Amplified DNA
was blunt ended with the Quick Blunting Kit (New England
Biolabs, NEB) and DNA sequences ligated into the firefly
luciferase vector, pGL3-promoter (pGL3p) linearized with SalI
(NEB) and dephosphorylated with calf intestinal alkaline phos-
phatase (NEB) according to manufacturer’s instructions. The ECR
fragment sequence and orientation within pGL3p was verified
through DNA sequencing.
Human embryonic kidney (HEK) 293 cells (ATCC, CRL-1573)
were transfected using FUGENE6 Transfection Reagent (Roche)
according to the manufacturer’s protocol and as previously
described [4]. HEK 293 cells were grown as previously described
on 60 mm plates (Fisher) for 24 hours to 40–50% confluency [4].
Cultures were co-transfected with 0.5 mg of the firefly luciferase
constructs containing the ECRs of interest and either 0.1 mgo f
control empty vectors (pcDNA3.1 or pEMSV) or 0.1 mgo f
expression plasmids pcDNA-Twist1 [3] (gift from Dr. Anthony
Firulli, Indiana University School of Medicine) and/or pEMSV-
E12 (gift from Dr. Jeffery Molkentin, Cincinnati Children’s
Hospital Medical Center, CCHMC). All samples were co-
transfected with 0.01 mg renilla luciferase (pRL-TK, promega)
reporter plasmid for normalization of transfection efficiency [4].
Transfected cells were incubated for 48 hours at 37uC with 5%
C02, then washed (1XPBS), and lysed (1X Passive Lysis Buffer,
Promega) according to the manufacturer’s protocol [4]. Cells were
subjected to one freeze thaw cycle to facilitate lysis, then thawed
and centrifuged at 13,000 rpm for 1 minute to collect cell debris.
Dual-luciferase (Promega) assays were performed according to the
manufacturer’s protocol with 20 ml of cell lysate supernatant used
to evaluate firefly luciferase and renilla luciferase levels using a
single sample reader Monolight luminometer (BD Pharmingen)
[4,21]. For all samples, firefly luciferase values were normalized
relative to renilla luciferase values. Average fold change and
standard error of the mean (SEM) were calculated from at least 3
independent co-transfection experiments performed in triplicate.
Statistical significance was determined by Student’s t-test (p#0.05).
Site-directed mutagenesis
Site-directed mutagenesis of Tbx20boxA, Cdh11-Intron1, and
Sema3C-Intron1 E-box consensus sequences was performed on each
ECR within pGL3p vector using QuickChange Site-Directed
Mutagenesis Kit (Stratagene) according to the manufacturer’s
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mutated at 3 nucleotides (ATNNAG) [22]. The following primers
and annealing temperatures were used for E-box mutagenesis:
Tbx20boxAMut (59- GCC TGT CTA ATT AGT ATT AAG AAC
GGA GGG C -39 and 59- CGG ACA GAT TAA TCA TAA TTC
TTG CCT CCC G -39,5 5 uC, 12 cycles), Cdh11-Intron1Mut (59-
GGT ACA ATG AAA GAA TTT AGT AAA TGA AGC AGA
TAA GCC C-39 and 59- GGG CTT ATC TGC TTC ATT TAC
AAA TGT CTT TCA TTG TAC C-39,6 2 uC, 16 cycles), Sema3C-
Intron1Mut (5- AAA CAT CTC TAG GGT CTC CTC ATT
CAG TGT GGT AGA GGC AGA G -39 and 59- CTC TGC
CTC TAC CAC ACT GAA TGA GGA GAC CCT AGA GAT
GTT T -39,5 5 uC, 12 cycles). The predicted nucleotide changes
were verified through DNA sequencing for each reporter plasmid.
Mutated constructs (Tbx20boxA-Mut, Cdh11-Intron1Mut, and Se-
ma3C-Intron1Mut) were then used for dual-luciferase assays as
described above.
Chromatin immunoprecipitation (ChIP)
In vivo binding of Twist1 protein to DNA was detected by ChIP
assay in mouse E12.5 ECCs and E17.5 remodeling atrioventricular
(AV) valves. Litters were generated from timed matings of FVBN
wild-type (Taconic) mice where the presence of a copulation plug
was considered E0.5. Pregnant females were sacrificed with CO2
inhalation and embryos isolated. Tissue was dissected from 10–12
atrioventricular canal (AVC) E12.5 ECCs or E17.5 AV valves [10].
Dissected ECCs and AV valves were placed in DMEM medium
(Invitrogen) supplemented with 10% FBS (HyClone) and 1%
penicillin-streptomycin (pen-strep, Invitrogen). Tissue was treated
with a final concentration of 3.7% formaldehyde (Sigma) for
10 minutes to cross-link protein/chromatin complexes followed by
lysis by sonication (Virsonic 60, Virtis) 2 times for 10 seconds with a
5-minute refractory period and an output of 5. ChIP was then
performed according to manufacturer’s protocol (EZChIP, Milli-
pore) modified by use of protein A-agarose beads (Millipore)
[4,23,24]. Immunoprecipitation (IP) was performed with a Twist1
specific antibody (Sigma T6451, 5 mg) or control normal rabbit IgG
(Cell Signaling, 5 mg). Eluted DNA from ChIP samples was
evaluated by quantitative polymerase chain reaction (qPCR)
relative to normal rabbit IgG control [25]. qPCR amplification
reactions were performed with initial denaturation of 94uC for
3 min, 25 cycles of 94uC for 20 s, annealing temperature dependent
based upon the primer set for 30 s, 72uC for 30 s, and final
extension at 72uC for 2 min. PCR amplification was performed
using the following primers and annealing temperatures: Tbx20box-
AChIP (59- AAG CAT GGA TTG TTG AGG AAG T -39 and 59-
CTA AGA GAA AGC AGG CTA CAT AAG -39,5 5 uC),
Cdh11Intron1E-box1 (59- TGC GAC TGA TAA GAC TGC CAT
TG -39 and 59- GAA AGG CCC ATT GTG CTG CTA C -39,
55uC), Cdh11Intron1E-box2ChIP (59- GAA AGG CCC ATT GTG
CTG CTA C -39 and 59- CTG CCT GAG CCT CCT GAC TG -
39,5 5 uC), Sema3CIntron1ChIP (59- GGA AAG TCA CCC ATA
AAA ATC AA -39 and 59- TAA ACA CAG CAT GCA ATC TCA
AA -39,5 6 uC), Rab39b39UTRChIP (59- CTG GAA TAT AAG ACA
ATC -39 and 59-CTG CAA TAA GTG GGT TTT -39,4 5 uC), and
Gadd45a-promoterChIP (59- GCT GAA TCA TGA AGC TGT AAC
TG -39 and 59- GGT TCA GGC AAT GCT TTT GT -39,5 5 uC).
SEM and fold enrichment were calculated relative to IgG control,




Double stranded siRNAs with a 39 dT overhang specific to
mouse Twist1 were designed using Block-it RNAi designer
(Invitrogen) [8]. To efficiently knockdown Twist1, MC3T3-E1
cells were transfected with a pool of 3 double stranded siRNAs
(total concentration of 200 nM) for each experiment. The siRNA
sequences were: mTwist1-1 (GCAAGAUUCAGACCCUCAA
and UUGAGGGUCUGAAUCUUGC), mTwist1-2 (GGUGU-
CUAAAUGCAUUCAU and AUGAAUGCAUUUAGACACC),
and mTwist1-3 (CCGCCAGAGAUUGUAGCAU and AUGA-
CAUCUAGGUCUCCGG). Scrambled siRNA (AAACAUGC-
CUAGAGAGAGC and GCUCUCUCUAGGCAUGUUU) was
used as a control. MC3T3-E1 cells were cultured in 60 mm dishes
for 24 hours in MEM-alpha medium (Invitrogen), 10% FBS, and
1% pen-strep and transfected at 50–60% confluency. Cells were
then washed 3 times with 1XPBS and incubated with 1 ml OPTI-
MEM (Invitrogen) during preparation of siRNA mixture for
transfection [8]. Lipofectamine 2000, OPTI-MEM, and 200 nM
siRNA were mixed according to manufacturer’s protocol and as
previously described [8]. The siRNA mixture (Lipofectamine
2000/OPTI-MEM/siRNA) was added to cells in OPTI-MEM
and incubated for 4–6 hours. The siRNA mixture/OPTI-MEM
was then removed and cells were incubated in MEM-alpha
media/10%FBS/1%pen-strep for an additional 48 hours. RNA
was isolated from all samples using Trizol Reagent (Invitrogen)
and additional purification was performed using RNeasy Mini Kit
(Qiagen) [10]. siRNA transfection efficiency in MC3T3-E1 cells
was evaluated utilizing Block-it Fluorescent Oligo (Invitrogen)
reagent transfected with Lipofectamine 2000 and imaged as
previously reported [7]. Percent transfection was calculated by
comparing the total number of fluorescently labeled cells to the
total nuclei in 10 fields of cells from 3 experiments. Transfection
efficiency was ,80% for three independent experiments (n=3).
siRNA knockdown of Twist1 was approximately 80% as assessed
by qPCR.
Affymetrix microarray hybridization and gene expression
analysis
Total purified mRNA isolated from Twist1 siRNA (siTwist1)
or Scrambled siRNA (siScr) transfected MC3T3-E1 cells was
submitted in biological triplicate to Cincinnati Children’s Hospital
Medical Center Affymetrix Microarray core for gene expression
analysis [10]. RNA integrity of all six samples was confirmed using
an Agilent 2100 Bioanalyzer (Agilent Technologies) and RNA
6000 Nano Assay [10]. Double stranded cDNA was generated
from 400 ng of each sample (3-siScrambled and 3-siTwist1) using
the TargetAMP1-Round Aminoallyl-RNA Amplification kit
(Epicenter). Biotin-labeled cRNA was synthesized with the IVT
Labeling Kit (Affymetrix) then chemically fragmented and
hybridized to Mouse Genome 430 2.0 Array (Affymetrix) using
standard protocols. Arrays were washed and stained with Fluidics
Station 450 (Affymetrix), scanned with GeneChip Scanner 3000
(Affymetrix), with the scanned gene expression data exported as
.CEL files. Data were loaded into GeneSpring Gx 7.3 software
(Agilent Technologies) and quantile normalization was performed
with robust multichip average (RMA) analysis [10]. Statistical
analysis (ANOVA) identified 5637 probe sets with significantly
differential gene expression (p#0.05) 5637 and 65 genes with $2.0
fold decreased gene expression. The complete MIAME compliant
data set is can be accessed through the GEO database with the
accession number GSE30953.
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Tissue from 10–12 E12.5 AVC ECCs and E17.5 AV valves of
FVBN wild-type mouse embryos was isolated with tungsten
needles in 1XPBS then placed in Trizol Reagent for RNA
isolation as previously described [4,10]. RNA was isolated from
MC3T3-E1 cells at 80–90% confluency cultured in a 100 mm
tissue culture dish (Fisher) using Trizol Reagent [10,26]. cDNA
was generated using Superscript cDNA kit (Invitrogen) with
800 ng of RNA. qPCR was performed as previously described [7].
For each primer set, standard curves generated with cDNA from
MC3T3 cells were used to determine cycle threshold, and all
samples were normalized for input based on expression levels of
housekeeping control gene, L7 [10]. The following primer sets and
annealing temperatures were used for qPCR analysis of murine
candidate target genes: Rab39b (59- GGC TCG ATC TCC ACC
AAA CG -39 and 59- ACC AGT TCC GGC TCA TTG TG -39,
62.5uC), Tubb3 (59- TAG ACC CCA GCG GCA ACT AT -39 and
59- GTT CCA GGT TCC AAG TCC ACC -39, 62.5uC), Gadd45a
(59- TGC TGC TAC TGG AGA ACG AC-39 and 59- CGA CTT
TCC CGG CAA AAA CAA A -39, 62.5uC), Serpinb9b (59- AAG
GAG TCC TGT TTT CGC TTC -39 and 59- CTG AGT CAT
CTG CCA ACA ACT -39, 60.0uC), Pa2g4 (59- CAG CAG GAG
CAA ACT ATC GC -39 and 59- GGC ATC ACC TTT CTC
ACA CAA G -39, 61.0uC), Trib3 (59- TGC AGG AAG AAA CCG
TGG GAG -39 and 59- CTC GTT TTA GGA CTG GAC ACT
TG -39, 61.0uC), Nras (59- ACT GAG TAC AAA CTG GTG
GTG G -39 and 59- TCG GTA AGA ATC CTC TAT GGT GG
-39, 61.0uC), and Sema3C (59- ACA GCA GGA AAA GCA GAA
ACA GGA -39 and 59- CAG CAG CCG ACA CAT CTT ACA
ATC -39, 59.0uC). Primer specificity was determined by DNA
sequencing following ligation of amplified fragment into pGEM-T
(Promega) vector. Previously validated primers were used for
amplification of Twist1, Osteonectin, Col2a1, and Col5a1 [10,27].
Average fold change of qPCR values for E17.5 AV valves was
compared to E12.5 ECCs set to 1.0, then the SEM was calculated
from 3 independent experiments performed in triplicate. Statistical
significance was determined by Student’s t-test (p#0.05).
Probe generation and In situ hybridization (ISH)
The following primer sequences and annealing temperatures
were used to generate PCR fragments for anti-sense riboprobes for
ISH: Tubb3 (59- TCT GGC GCC TTT GGA CAC CTA TT -39
and 59- CAT GCG CCC ACG GAA GAC AGT -39,6 4 uC),
Rab39b (59- GCG AGC GCA GCA TCC ATC C -39 and 59-
CTT CAC CCC TCC CCA ACC CTC CTG -39,5 4 uC), and
Serpinb9b (59- AGT CCA GGC AAT GCA TAA ACA GC -39 and
59- GGG CCA CCA CCT AAG CAG AGA -39, 56.8uC). All
sequences were amplified by RT-PCR of MC3T3-E1 cell cDNA.
Gadd45a primers were previously described, and the Sema3C
plasmid (Sema3CpSport6) was a kind gift from Dr. Yutaka Yoshida,
CCHMC [28]. Twist1 ISH probe was a kind gift from Dr. James
Martin, Texas A&M Health Sciences Center [29]. All primers
PCR fragments were ligated into pGEM-T vector (Promega) using
Rapid T4 DNA Ligase (Roche, 11635) [4]. Amplification of
predicted sequences by each primer set was confirmed by DNA
sequencing. Digoxigenin (DIG)-labeled ISH antisense riboprobes
were generated as previously described with the following
modifications [30]. The Sema3CpSport6 plasmid was linearized
with SalI and probe synthesized with T7 polymerase. Serpinb9b and
Gadd45a plasmids were linearized with NotI and probes synthe-
sized with SP6 polymerase. Tubb3 and Rab39b plasmids were
linearized with NcoI and probes synthesized with SP6 polymerase.
The Twist1 plasmid was linearized with XbaI and probe
synthesized with T3 polymerase.
FVBN wild-type mouse E12.5 whole embryos and E17.5 hearts
were isolated and fixed in 4% paraformaldehyde (PFA, Electron
Microscopy Sciences), then embedded in paraffin wax as
previously described [31]. Paraffin-embedded samples were
sectioned at a thickness of 14 mm. ISH was performed as
previously described with the following modifications [7]. Sections
were treated with 20 mg/ml proteinase K/PBS for 10 minutes at
37uC. Hybridization was carried out as previously described. For
all ISH experiments, color reactions with tetrazolium/5-bromo-4-
chloro-3-indolyl phosphate (NBT/BCIP, Roche) on E12.5 em-
bryos and E17.5 heart sections were stopped at the same time for
each probe. Development of color reactions ranged from 4 to
16 hours.
Results
Twist1 binds and promotes gene expression from an ECR
located upstream of cTbx20
In ECCs Tbx20 gene expression is responsive to Twist1,
however, whether this relationship is direct or indirect has not
been reported previously [8]. rVista 2.0 analysis was performed for
Tbx20 gene sequence alignment using chicken as the base genome
in order to determine if Tbx20 contains candidate DNA sequences
directly regulated by Twist1. An ECR (conserved from human to
zebrafish) and containing a conserved E-box consensus sequence
was identified 215040 to 214862 base pairs (bps) upstream from
the cTbx20 transcriptional start site (+1 site), which will be referred
to as Tbx20boxA (Figure 1A). Additional ECRs were identified that
are located further away from the +1 site of Tbx20. However, these
ECRs are more than 20 Kb from the +1 site and do not contain E-
box consensus sequences.
Twist1 responsiveness of the Tbx20boxA ECR was determined
by co-transfection assays in HEK 293 cells. The Tbx20boxA
sequence was linked to the minimal SV40 promoter of pGL3p,
which contains a firefly luciferase reporter, to generate
Tbx20boxA/pGL3p. Co-transfection of Tbx20boxA/pGL3p with a
Twist1 expression plasmid results in approximately 2.75-fold
increase in reporter gene activity compared to Tbx20boxA/pGL3p
co-transfected with control empty vector (pCDNA, Figure 1B).
Co-transfection of Tbx20boxA/pGL3p with E12 alone has no
effect on reporter gene expression. However, co-transfection of
Tbx20boxA/pGL3p with both Twist1 and E12 expression vectors
results in approximately 3.25-fold increase in reporter gene
activation. These experiments confirm that Tbx20boxA has
enhancer activity when linked to a minimal SV40 promoter.
To confirm that the E-box consensus sequence is essential for
Twist1 to promote gene expression from Tbx20boxA/pGL3p,s i t e -
directed mutagenesis was performed to generate Tbx20boxAMut/
pGL3p (CATATG to ATTAAG, Figure 1A). Co-transfection of
Tbx20boxAMut/pGL3p with Twist1 alone, E12 alone, or Twist1
and E12 together confirms that the E-box consensus sequence is
necessary for Twist1 to promote gene expression from
Tbx20boxA/pGL3p (Figure 1A,B). ChIP assays were utilized to
assess Twist1 direct binding to Tbx20boxA in vivo during murine
early (E12.5 ECC) and late (E17.5 AV valve) valve development
(Figure 1C). Immunoprecipitation with anti-Twist1 demon-
strates that Twist1 is bound to the Tbx20boxA sequence in
E12.5 ECCs evident by approximately 3.75-fold enrichment
compared to IgG control. However, no enrichment in Twist1
binding to Tbx20boxA was observed in E17.5 AV valves in which
Twist1 gene expression is downregulated (Figure 1C). Thus
Twist1 promotes gene expression from a novel enhancer
associated with Tbx20, Tbx20boxA, in an E-box dependent
manner in transfected cells. Furthermore, Twist1 directly binds
Twist1 Target Genes in Heart Valve Development
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heart valves, in vivo.
Twist1 binds and promotes gene expression from an ECR
in Intron1 of Cdh11
The adhesion-migration molecule Cdh11 (OB-Cadherin) is highly
expressed in ECC mesenchymal cells [8]. Furthermore, in chick
ECC cultures Cdh11 expression is responsive to Twist1 expression.
Genomic alignment and transcription factor binding site analysis
was performed to identify ECRs containing E-box consensus
sequences in the Cdh11 gene using chicken as the base genome. An
ECR (conserved in human to zebrafish) containing two conserved
E-box consensus sequences was identified within the first intron of
chicken Cdh11 (Cdh11-Intron1, +36256 to +36552 bps from the +1
site, Figure 2A). Cdh11-Intron1 sequence was amplified from E4.5
chicken genomic DNA and linked to the minimal SV40 promoter
of the pGL3p luciferase reporter plasmid. In co-transfection
assays, Twist1 promotes gene expression from Cdh11-Intron1/
pGL3p approximately 2.75-fold versus Cdh11-Intron1/pGL3p with
empty vector, while co-transfection with E12 alone has no
observed effect on reporter gene expression (Figure 2B). Co-
transfection with Twist1 and E12 together results in activation of
approximately 3.25-fold that is not statistically different from co-
transfection with Twist1 alone. These data identify a novel Twist1-
responsive enhancer within the first intron of Cdh11, Cdh11-Intron1.
Since two E-box consensus sequences are present within Cdh11-
Intron1/pGL3p, Twist1 could bind and promote gene expression
from either or both E-box consensus sites (E-box1 or E-box2,
Figure 2A). To examine whether Twist1 preferentially activates E-
box1 or E-box2, site-directed mutagenesis was performed on E-
box1 (CATTTG to ATTTAG, Cdh11-Intron1Mut/pGL3p,
Figure 2A). Loss of E-box1 in Cdh11-Intron1Mut/pGL3p eliminates
reporter gene activity by Twist1, E12, or Twist1 with E12,
indicating that Twist1 transactivation is dependent upon an intact
E-box1 consensus sequence (Figure 2B).
To examine the ability of Twist1 to directly bind to the Cdh11-
Intron1 ECR in developing heart valves in vivo, ChIP was
performed in mouse E12.5 ECCs and E17.5 AV valves
(Figure 2C). Twist1 immunoprecipitation is enriched 6.5- to 8-
fold for a region of Cdh11-Intron1 that contains only E-box1, but no
Twist1 binding is detected for a region of Cdh11-Intron1 that
contains only E-box2, relative to the IgG control. Therefore,
Twist1 preferentially binds and promotes gene expression from the
Cdh11-Intron1 E-box1 sequence (Figure 2C). Twist1 immunopre-
cipitation is not enriched with Cdh11-Intron1 regions that contain
either E-box1 or E-box2 in E17.5 AV valves (Figure 2C).
Figure 1. Twist1 binds and promotes gene expression from an ECR associated with Tbx20 (Tbx20boxA). A. An E-box-containing ECR is
located 215040 to 214862 base pairs (bps) from the chicken Tbx20 transcriptional start site (+1). Cross-species genomic alignment of the E-box
consensus sequence (shaded grey) and mutated sequence (mutated bps indicated by *) are indicated. B. Tbx20boxA or Tbx20boxA-Mut plasmids were
co-transfected into HEK293 cells, with empty vector or with Twist1, E12, or Twist1 and E12 expression vectors followed by luciferase reporter assays.
Fold change over the empty vector control set to 1 is shown with standard error of the mean (SEM). C. ChIP assays were performed with anti-Twist1 in
mE12.5 ECCs and mE17.5 AV valves quantified by qPCR. Fold enrichment was evaluated by comparing anti-Twist1 IP of E12.5 ECCs or anti-Twist1 IP of
E17.5 valves versus IgG (negative control) set to 1. Statistical significance was determined by Student’s t-Test, p=#0.05 indicated by *. All
experiments were performed in biological and technical triplicate. Histograms are a compilation of n=3 experiments.
doi:10.1371/journal.pone.0029758.g001
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Intron1 in E12.5 ECC mesenchymal cells and promotes gene
expression specifically through the E-box1 consensus site.
Identification of Twist1 candidate genes by siRNA-
mediated loss of function in MC3T3-E1 cells
In order to identify additional Twist1 target gene candidates, an
siRNA-mediated knockdown and gene expression profiling
approach was employed in transfected MC3T3-E1 preosteoblast
cells. MC3T3-E1 cells are a preosteoblast cell line that expresses
high levels of Twist1 and has extensive shared gene expression with
E12.5 ECCs [10,20]. Therefore, MC3T3-E1 cells were chosen as
an appropriate in vitro system for identification of Twist1 candidate
target genes. MC3T3-E1 cells were transfected with a combina-
tion of 3 siRNAs specific to Twist1 (siTwist1) or scrambled control
siRNA (siScr). Twist1 siRNA transfection resulted in approxi-
mately 80% Twist1 mRNA knockdown verified through qPCR
and loss of protein as determined by immunohistochemistry
(Figure 3A and data not shown). RNA was collected from
MC3T3-E1 cells transfected with siScr or siTwist1 and subjected
to gene expression profiling using Affymetrix Microarray analysis.
Gene expression data were normalized and prioritized according
to p-value (p#0.05) and fold change ($2.0 fold) comparing
MC3T3-E1 cells treated with either siTwist1 or siScr. A total of 65
genes were identified with decreased expression by at least 2-fold
in cells transfected with siTwist1 versus siScr.
The 65 genes with $2-fold decreased expression with
knockdown of Twist1 were subjected to PANTHER analysis for
biological function classification. The majority of the differentially
expressed genes are classified into biological functions that are
consistent with known Twist1 functions during development and
disease (Figure 3B, Table 1) including cell cycle-proliferation
Figure 2. Twist1 binds and promotes gene expression from an ECR within Intron1 of Cadherin-11 (Cdh11-Intron1). A. An E-box-
containing ECR is located +36256 to +36552 bps from the chicken Cdh11 transcriptional start site (+1). Cross-species genomic alignment of the E-box
consensus sequence (shaded grey) and mutated sequence (mutated bps indicated by *) are indicated. B. Cdh11-Intron1 or Cdh11-Intron1Mut plasmids
were co-transfected into HEK293 cells with empty vector or with Twist1, E12, or Twist1 and E12 expression vectors and luciferase reporter assays
performed. Fold change over the empty vector control set to 1 is shown with SEM. C. ChIP assays were performed with anti-Twist1 in mE12.5 ECCs
and mE17.5 AV valves and quantified by qPCR. Fold enrichment was evaluated by comparing anti-Twist1 IP of mE12.5 ECCs or anti-Twist1 IP of
mE17.5 valves versus IgG (negative control) set to 1. Statistical significance was determined by Student’s t-Test, p=#0.05 indicated by *. All
experiments were performed in biological and technical triplicate. Histograms are a compilation of n=3 experiments.
doi:10.1371/journal.pone.0029758.g002
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extracellular matrix (11%). The remaining genes were classified
into an ‘‘other’’ (33%) category, consisting of biological classifica-
tions such as ion transport, calcium binding, biotin metabolism,
and chemotaxis. Thus Twist1 knockdown in MC3T3-E1 pre-
osteoblast cells results in gene expression changes consistent with
known Twist1 regulation of cell proliferation, adhesion-migration,
signaling, and ECM gene expression.
Gene expression changes of candidate Twist1 target genes were
validated by determination of transcript expression levels of the
nine most differentially expressed genes by qPCR of RNA isolated
from MC3T3-E1 cells treated with siTwist1 versus siScr. Each of
the nine genes chosen for further analysis has been categorized as
related to functions regulated by Twist1 (Table 1). Decreased
expression of Sema3c, Tubb3, Gadd45a, Rab39b, Serpinb9b, Pa2G4,
Col5a1, Trib3, and Nras with loss of Twist1 was confirmed in
MC3T3-E1 cells. The differential expression of these Twist1
candidate target genes was validated by qPCR of RNA isolated
from MC3T3-E1 cells transfected with siTwist1 or siScr. Sema3C,
Tubb3, Gadd45a, Rab39b, Serpinb9b, Col5a1, Trib3, and Nras
expression were significantly decreased in siTwist1 versus siScr
treated MC3T3-E1 cells (Figure 4A). Expression analysis of the
previously identified Twist1 target gene Col2a1 was included as a
control for differential expression (Figure 4A,B). Differential
expression of one candidate gene from the microarray, Pa2G4,
was not validated in MC3T3-E1 cells. These data indicate that the
differential expression of multiple candidate Twist1 target genes
identified through microarray gene profiling was validated in
MC3T3-E1 cells.
Although a substantial number of genes are expressed in both
the developing heart valves and MC3T3-E1 cells, a subset of genes
are differentially expressed between preosteoblast cells and heart
valve progenitors, that terminally differentiate into distinct cell
types [10]. Therefore, expression of candidate Twist1 target genes
in the developing heart was examined in vivo. To examine
expression of candidate target genes during early versus late heart
valve development, qPCR was performed using RNA isolated
from mouse E12.5 ECCs, that express high levels of Twist1,
compared to RNA isolated from E17.5 AV remodeling valve
leaflets, with negligible Twist1 expression (Figure 4A,B). Expres-
sion of Sema3C, Tubb3, Rab39b, Serpinb9b, PA2G4, and Trib3 were
significantly decreased in E17.5 AV valves versus E12.5 ECCs
(Figure 4B). Two genes with decreased expression in MC3T3 cells
treated with siTwist1, Col5a1 and Nras, showed no differential
expression in E17.5 AV valves versus E12.5 ECCs, which may
reflect gene regulatory differences in valve progenitor cells and
preosteoblast lineages. Pa2G4 gene expression changes detected by
microarray were not confirmed in Twist1 siRNA treated MC3T3-
E1 cells, but Pa2G4 has decreased gene expression in late
developing heart valves. These differences could be due to
transcript variants of Pa2G4 differentially detected by microarray
and qPCR, or Pa2G4 may not be directly regulated by Twist1 and
thus was not analyzed further. Together these studies demonstrate
that multiple candidate Twist1 target genes identified by
microarray analysis in MC3T3 cells also are expressed during
early heart valve development and are decreased during heart
valve remodeling, similar to Twist1.
To determine whether the candidate Twist1 target genes exhibit
expression patterns similar to Twist1 during heart valve develop-
ment in E12.5 ECCs and E17.5 remodeling valve leaflets in vivo,
ISH was performed with the five most differentially expressed
genes associated with cell proliferation and migration identified
from microarray gene expression profiling (Figure 5). Sema3C,
Tubb3, Rab39b, Serpinb9b, and Gadd45a genes assessed by ISH are
responsive to Twist1 in MC3T3-E1 cells and are differentially
expressed coincident with Twist1 in mouse valve development as
determined by qPCR. Transcript expression and localization of
Twist1 candidate target genes, Sema3C (Figure 5A,B), Tubb3
(Figure 5C,D), Rab39b (Figure 5E,F), Serpinb9b (Figure 5G,H), and
Gadd45a (Figure 5I,J) is evident in ECCs, that express high levels of
Twist1 (Figure 5K,L). In addition, expression of each is decreased
during later valve development (E17.5 mitral valves), when Twist1
expression is low. Sema3C, Tubb3, Rab39b, Serpinb9b, and Gadd45a
also have sparse expression in the interventricular septum (IVS) of
the E12.5 heart (Figure 5A,C,E,G,I). Although nearly absent from
the E17.5 mitral valves, Sema3C and Serpinb9b are expressed in the
IVS and in AVC myocardium (Figure 5B). Additionally, Tubb3
retains expression at E17.5 in the distal tips of the mitral valve
leaflets (Figure 5D). Sema3C, Serpinb9b, and Tubb3 may have
Twist1-dependent and independent expression since they exhibit
unique and overlapping expression patterns compared to Twist1
(Figure 5K,L). Thus expression of the Twist1 downstream
candidate genes Sema3C, Tubb3, Rab39b, Gadd45a, and Serpinb9b
is similar toTwist1 during heart valve development.
Twist1 directly binds to ECRs associated with Sema3C,
Gadd45a, and Rab39b
DiRe, Trafac, rVista2.0, and oPOSSUM analyses were
employed to identify ECRs containing E-box consensus sequences
Figure 3. Knockdown of Twist1 results in decreased expression
of genes associated with mesenchymal cell functions. A. qPCR of
Twist1 and Osteonectin expression confirms knockdown of Twist1 in
MC3T3-E1 pre-osteoblast cells transfected with siTwist1 versus siScr
controls. Fold change relative to siScr transfected cells, set to 1, 6 SEM
is shown. Statistical significance was determined by Student’s t-Test,
p=#0.05 indicated by *. All experiments were performed in biological
and technical triplicate. Histograms are a compilation of n=3
experiments. B. Twist1 candidate target genes from gene expression
profiling with $2.0 fold decreased grouped by functional classifications
are represented in a pie graph.
doi:10.1371/journal.pone.0029758.g003
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siTwist1 vs. siScr transfected MC3T3-E1 cells.
Adhesion-Migration
Ref Seq Gene ID Gene Name Fold Change
NM_013657 Sema3C Semaphorin 3C 24.95
NM_023279 Tubb3 Tubulin, beta 3 24.27
NM_010717 Limk1 LIM-domain containing, protein kinase 22.74
NM_145953 Cth Cystathionase (cystathionine gamma-lyase) 22.60
NM_010833 Msn Moesin 22.19
NM_008659 Myo1c Myosin IC 22.16
NM_001081053 Itga10 Integrin, alpha 10 22.12
NM_053083 Loxl4 Lysyl oxidase-like 4 22.06
NM_011693 Vcam1 Vascular cell adhesion molecule 1 22.09
Extracellular Matrix
NM_015734 Col5a1 Procollagen, type V, alpha 1 22.99
NM_011434 Sod1 Superoxide dismutase 1, soluble 22.42
NM_007729 Col11a1 Procollagen, type XI, alpha 1 22.40
NM_025711 Aspn Asporin 22.30
NM_010917 Nid1 Nidogen 1 22.21
NM_010721 Lmnb1 Lamin B1 22.17
NM_008695 Nid2 Nidogen 2 22.12
Signaling Molecules
NM_011452 Serpinb9b Serine (or cysteine) peptidase inhibitor, clade B, member 9b 23.41
NM_175093 Trib3 Tribbles homolog 3 (Drosophila) 22.95
NM_146162 Tmem119 Transmembrane protein 119 22.54
NM_028744 Pi4k2b Phosphatidylinositol 4-kinase type 2 beta 22.53
NM_019681 Freq Frequenin homolog (Drosophila) 22.25
NM_024454 Rab21 RAB21, Member RAS oncogene family 22.18
NM_009369 Tgfbi Transforming growth factor, beta induced 22.17
NM_021532 Dact1 Dapper homolog 1, antagonist of beta-catenin (xenopus) 22.20
NM_008924 Prkar2a Protein kinase, cAMP dependent regulatory, type II alpha 22.12
NM_025954 Pgp Phosphoglycolate phosphatase 22.07
NM_008845 Pip4k2a Phosphatidylinositol-5-phosphate 4-kinase, type II, alpha 22.05
Cell Cycle-Proliferation
NM_007836 Gadd45a Growth arrest and DNA-damage-inducible 45 alpha 24.13
NM_021288 Tyms Thymidylate synthase 23.91
NM_175122 Rab39b RAB39B, Member RAS oncogene family 23.64
NM_011119 Pa2g4 Proliferation-associated 2G4 23.13
NM_010937 Nras Neuroblastoma ras oncogene 22.73
NM_010485 Elavl1 ELAV (Embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu
antigen R)
22.62
NM_145953 Cth Cystathionase (cystathionine gamma-lyase) 22.60
NM_011641 Trp63 Transformation related protein 63 22.40
NM_009234 Sox11 SRY-box containing gene 11 22.25
NM_001081323 Mphosph9 M-phase phosphoprotein 9 22.25
NM_009906 Tpp1 Tripeptidyl peptidase I 22.24
NM_054102 Ivns1abp Influenza virus NS1A binding protein 22.22
NM_024184 Asf1b ASF1 Anti-silencing function 1 homolog B (S. cerevisiae) 22.15
NM_009881 Cdyl Chromodomain protein, Y chromosome-like 22.12
NM_008726 Nppb Natriuretic peptide precursor type B 22.11
NM_007788 Csnk2a1 Casein kinase 2, alpha 1 polypeptide 22.04
NM_020618 Smarce1 SWI/SNF related, matrix associated, actin dependent regulator of
chromatin, subfamily e, member 1
22.00
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microarray gene expression profiling (Table 1). ECRs were
selected for further validation based on the presence of an E-box
consensus sequence identified by all bioinformatics programs used
to analyze genomic alignments and sequence homology between
at least mouse and human, since many of the genes identified are
not entirely conserved across species. ECRs with these criteria
were identified for Twist1 candidate target genes Sema3C, Gadd45a,
and Rab39b. Sema3C is the gene with the most decreased gene
expression (24.95 fold, Table 1) in the siTwist1 versus siScr
microarray gene profiling. An ECR was identified within the 1
st
intron (+949 to +1125 bps from the +1 site) of Sema3C (Sema3C-
Intron1, Figure 6A). In co-transfection assays to assess enhancer
activity, Twist1 promotes reporter gene expression from Sema3c-
Intron1/pGL3p approximately 2.25-fold. In contrast co-transfection
with E12 alone does not result in reporter gene induction
compared to Sema3C-Intron1/pGL3p co-transfected with the empty
vector (Figure 6B). In co-transfection assays of Sema3C-Intron1/
pGL3p with Twist1 and E12 together, reporter gene expression
increases 1.5-fold and is not statistically different from co-
transfection with Twist1 alone. To examine whether the E-box
consensus sequence in Sema3C-Intron1 is necessary for Twist1 trans-
activation, site-directed mutagenesis was performed to create
Sema3C-Intron1Mut/pGL3p (CATCTG to ATTCAG, Figure 6A).
Co-transfection of Sema3C-Intron1Mut/pGL3p with Twist1, E12, or
Twist1 and E12 together does not promote reporter gene
expression, indicating that Twist1 requires the E-box consensus
sequence for induction of gene expression from Sema3C-Intron1
(Figure 6B). Furthermore, ChIP experiments with anti-Twist1
performed on protein:DNA complexes isolated from ECCs (E12.5
Adhesion-Migration
Ref Seq Gene ID Gene Name Fold Change
NM_010067 Trdmt1 tRNA aspartic acid methyltransferase 1 22.00
doi:10.1371/journal.pone.0029758.t001
Table 1. Cont.
Figure 4. qPCR validation of differential expression of Twist1 candidate target genes in siRNA-transfected MC3T3-E1 cells and in
ECC and remodeling valves in vivo. A. qPCR was performed to determine the level of expression of candidate Twist1 target genes in MC3T3-E1
cells transfected with siTwist1 versus siScr control. Fold change in expression relative to the level in siScr control cells is shown. B. qPCR was
performed to determine the level of expression of Twist1 candidate target genes in mouse E17.5 AV valves versus E12.5 ECCs. Fold change in
expression relative to the level in E12.5 ECCs is shown. qPCR determination of the expression of the known Twist1 target gene Col2a1 was included as
a positive control. Statistical significance was determined by Student’s t-Test, p=#0.05 indicated by *. All experiments were performed in biological
and technical triplicates. Histograms are a compilation of n=3 experiments.
doi:10.1371/journal.pone.0029758.g004
Twist1 Target Genes in Heart Valve Development
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e29758ECCs) and remodeling valves (E17.5 AV valves) confirms that
Twist1 directly binds to the Sema3C-Intron1 sequence preferentially
in ECCs in vivo (Figure 6C).
The expression level of the DNA repair enzyme-encoding gene
Gadd45a decreased -4.13 fold in siTwist1 versus siScr treated cells,
and an ECR containing an E-box consensus sequences was
identified near the 59-promoter region (Gadd45a-promoter, 23240 to
23456 bps from the +1 site, Figure 7A, Table 1). Additionally,
expression of the Ras oncogene family member Rab39b is
significantly decreased by 23.64 fold in siTwist1 versus siScr
treated cells, and an E-box containing ECR was identified within
the 39UTR of Rab39b (Rab39b-39UTR, +5891 to +6093 bps from
the +1 site, Figure 7C, Table 1). Co-transfection assays with
Gadd45a-pr/pGL3p or Rab39b-39UTR/pGL3p with Twist1 alone
or Twist1 and E12 together, but not E12 alone, induced reporter
gene expression by approximately 3.25-fold, respectively
(Figure 7B,D left panels). Furthermore, ChIP assays on developing
heart valves with anti-Twist1 show increased Twist1 binding to
Gadd45a-pr (6.5-fold enrichment) and Rab39b-39UTR (3.5-fold
enrichment) in early E12.5 ECCs relative to later E17.5 AV valves
(Figure 7B,D right panels). These data indicate that enhancers
associated with Twist1 candidate target genes, Gadd45a and
Rab39b, are responsive to Twist1 in co-transfection assays and are
directly bound by Twist1 during heart valve development.
Discussion
The bHLH transcription factor Twist1 is well established as an
essential regulator of mesenchymal cell maintenance, however,
identification of Twist1 transcriptional targets remains incomplete.
In this study, we report multiple direct Twist1 transcriptional
target genes identified through candidate and global gene profiling
approaches. These genes all have functions regulating the critical
mesenchymal cell characteristics of cell proliferation and migra-
tion. Twist1 promotes these cellular functions in various cell types
during development, such as developing heart valves, and also in
metastatic cancers. Elucidation of Twist1 transcriptional hierar-
chies regulating cell proliferation and migration will further the
understanding of the molecular mechanisms by which Twist1
functions in heart development and cancer progression.
We have identified Twist1-responsive ECRs, predicted to act as
gene enhancers, associated with Tbx20, Cdh11, Sema3C, Gadd45a,
and Rab39b genes that promote cell proliferation and migration.
These enhancers are directly bound by Twist1 in developing heart
valves, and conserved E-box consensus sequences were identified
that are required for Twist1-responsive gene expression. Unlike
other bHLH transcription factors, whose transcriptional activity
requires paired E-box consensus sequences, Twist1 appears to only
require one E-box consensus site to promote gene expression [32].
With the exception of Cdh11, each of the ECRs identified in this
study contains a single E-box consensus sequence. Conversely,
Cdh11-Intron1 contains 2 E-box consensus sequences, however,
Twist1 binding and gene induction was detected only for E-box1.
rVista2.0, oPOSSUM, DiRE, and Trafac analysis for transcription
factor binding sequences revealed that each identified enhancer
has additional conserved transcription factor binding consensus
sequences [16–19]. Enhancer sequences identified in these studies
are located in upstream genomic regions, proximal to the gene, in
39UTR, and intronic gene regions, consistent with locations of
previously identified enhancers within the genome [33]. Interest-
ingly, regions within close proximity to the E-box consensus site
are enriched for A/T sequences, relative to more distal flanking
regions. However, no common binding sequences within close
proximity to the E-box consensus site of the Twist1 responsive
ECRs were identified (Figures S1, S2, S3, S4). From these data, we
predict that Twist1 does not require a specific co-factor protein to
promote gene expression from its downstream target genes.
Figure 5. Expression of Sema3C, Tubb3, Rab39b, Serpinb9b, and
Gadd45a is similar to Twist1 in developing mouse heart valves.
In vivo localized expression of Twist1 candidate target genes Sema3C
(A,B), Tubb3 (C,D), Rab39b (E,F), Serpinb9b (G,H), and Gadd45a (I,J), was
determined relative to Twist1 (K,L) in mouse E12.5 ECCs (A, C, E, G, I, and
K) and E17.5 AV valves (B, D, F, H, J, and L) by in situ hybridization of
heart sections. The arrows indicate areas of candidate target gene
transcript expression. (IVS=interventricular septum, ECC=endocardial
cushion, and MV=mitral valve).
doi:10.1371/journal.pone.0029758.g005
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these experiments, Twist1 binds to the E-box consensus sequence
as either a homodimer or heterodimer with E-proteins [11]. In
other systems, bHLH dimer composition dictates target gene
responsiveness, but dimer-specificity of Twist1 function in heart
valve development has not yet been determined [3,34,35].
Identified Twist1 target genes involved in cell migration include
Sema3C and Cdh11. Sema3C is the gene with the greatest decrease in
expression resulting from in siTwist1 treatment of MC3T3-E1
cells (Table 1). Previous studies have demonstrated that Sema3C
promotes cell migration of axons, neural crest cells, and metastatic
cancer cells [36,37]. Sema3C null mice die within the first
24 hours of life from persistent truncus arteriosus and aortic arch
malformations due to neural crest migration defects [38]. Similar
to Twist1, Sema3C is important for NCC contribution to OFT
development, but a role in heart valve development has not
previously been reported [38,39]. The identification of a Twist1-
responsive ECR bound by Twist1 in ECCs supports Twist1
activation of Sema3C in ECC mesenchymal cells. Whether this
hierarchy exists in migrating NCC will require additional
investigation. The Twist1-responsive gene, Cdh11, also promotes
cell migration and has overlapping expression with Twist1 in
preosteoblast cells, neural crest cells, preadipocytes, and heart
valve mesenchymal cells [8,40,41]. Since Cdh11 is expressed in
multiple migratory cell types, we predict that Twist1 activates
Cdh11 to promote cell migration in ECC mesenchymal cells of the
developing heart valves. Additional Twist1 target genes involved
in cell migration include N-cadherin, identified in cancer cells, and
Zyxin, identified in ECC mesenchymal cells [13,15,42]. Together
these studies provide accumulating evidence that Twist1 coordi-
nately regulates multiple downstream target genes to promote cell
migration in ECC mesenchymal cells, as well as in other
embryonic and cancer cell types.
Twist1 promotes cell proliferation in ECC mesenchymal cells,
in addition to other mesenchymal progenitor populations, and
also in metastatic cancer cells [5,11]. Nevertheless, the transcrip-
tional hierarchies by which Twist1 promotes cell proliferation are
largely uninvestigated. Our studies identified two direct tran-
scriptional targets of Twist1, Gadd45a and Rab39b, which have
functions in regulation of cell proliferation during embryogenesis
and in cultured cells, respectively [43,44]. However, Gadd45a and
Rab39b expression during heart valve development has not
previously been reported. Expression of Gadd45a is responsive to
multiple cellular stresses, and promotes genomic stability through
prevention of DNA damage [28]. Rab39b belongs to the Rab
group in the Ras family of small GTPases, which propagate
TGF-beta signaling through receptor recycling within the cell
inducing cellular proliferation [44]. Additional Twist1 candidate
Figure 6. Twist1 binds and promotes gene expression from an ECR within Intron1 of Semaphorin3C (Sema3C). A. An ECR is located +949
to +1125 bps from the mouse Sema3C +1 site. Cross-species genomic alignment of the E-box consensus sequence (shaded grey) and mutated
sequence (mutated bps indicated by *) are indicated. B. Sema3C-Intron1 or Sema3C-Intron1Mut was co-transfected into HEK293 cells with empty
vector or with Twist1, E12, or Twist1 and E12 expression vectors and luciferase reporter assays performed. Fold change over the empty vector control
set to 1 is shown with SEM. C. ChIP assays were performed with anti-Twist1 in mouse E12.5 ECCs and E17.5 AV valves and quantified by qPCR. Fold
enrichment was evaluated by comparing anti-Twist1 IP of E12.5 ECCs or anti-Twist1 IP of E17.5 valves versus IgG (negative control) set to 1. Statistical
significance was determined by Student’s t-Test, p=#0.05 indicated by *. All experiments were performed in biological and technical triplicate.
Histograms are a compilation of n=3 experiments.
doi:10.1371/journal.pone.0029758.g006
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promote proliferation of cancer cells and dendritic cells,
respectively [45,46]. Thus Twist1 promotes cell proliferation in
ECC mesenchymal cells, through regulation of multiple genes,
including Gadd45a and Rab39b. It is likely that these regulatory
interactions also are important for cell cycle regulation in other
mesenchymal cells in the embryo, as well as in cancer cell cycle
progression.
During heart valve development, Twist1, along with its target
gene Tbx20, regulate the transition from mesenchymal ECC to
remodeling valve leaflet [8]. Prolonged expression of Twist1
during heart valve development leads to increased cell prolifera-
tion and expression of primitive ECM proteins during heart valve
remodeling stages [4]. Additionally, human adult and pediatric
diseased aortic valves exhibit increased expression of Twist1,
induction of mesenchymal gene expression, increased cell
Figure 7. Twist1 binds and promotes gene expression from ECRs associated with Gadd45a and Rab39b. A. An E-box containing ECR is
located 23240 to 23456 bps from the mouse Gadd45a +1 site with the E-box sequence indicated by grey shading. B. (left) Gadd45a-promoter
plasmid was co-transfected into HEK293 cells with empty vector or with Twist1, E12, or Twist1 and E12 expression vectors and luciferase reporter
assays performed (left). Fold change over the empty vector control set to 1 is shown with SEM. ChIP assays were performed with anti-Twist1 in mouse
E12.5 ECCs and mE17.5 AV valves versus IgG (negative control) set to 1 (right). C. An E-box containing ECR is located within the mRab39b39UTR, +5891
to +6093 bps from mRab39b +1 site with the E-box indicated by grey shading. D. Rab39b-39UTR was co-transfected into HEK293 cells with empty
vector or with Twist1, E12, or Twist1 and E12 expression vectors and luciferase reporter assays performed (left). Fold change over the empty vector
control set to 1 is shown with SEM. ChIP assays were performed with anti-Twist1 in mouse E12.5 ECCs and E17.5 AV valves versus IgG (negative
control) set to 1 (right). Statistical significance was determined by Student’s t-Test, p=#0.05 indicated by *. All experiments were performed in
biological triplicate. Histograms are a compilation of n=3 experiments.
doi:10.1371/journal.pone.0029758.g007
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PLoS ONE | www.plosone.org 12 December 2011 | Volume 6 | Issue 12 | e29758proliferation, and disruption of ECM organization [4,8,47]. These
characteristics of diseased heart valves are in accordance with
Twist1 functions observed in ECC mesenchymal cells. However, it
is not clear if these regulatory interactions have reparative or
pathologic functions in heart valve disease. It is likely that the same
Twist1-activated regulatory hierarchies are important in the
development of various cell types, including osteoblast, neural
crest cells, and cancer cells. Therefore manipulation of Twist1-
mediated regulatory events could be used to develop therapeutic
strategies related to both human heart valve disease and cancer
progression [5,48].
Supporting Information
Figure S1 Tbx20boxA ECR cross species genomic
alignment and conserved transcription factor binding
sites. The chicken Tbx20boxA genomic sequence was utilized for
luciferase assays and ChIP assays. Genomic alignment with
corresponding zebrafish (NW_001877680.2), rat (NW_047798.2),
mouse (NW_001030907.1), and human (NW_001839003.1)
conserved sequences is shown. The dashed boxes indicate
predicted transcription factor binding sites, and the black lines
represent the location of primers used for ChIP assays.
(TIF)
Figure S2 Cdh11-Intron1 ECR cross species genomic
alignment and conserved transcription factor binding
sites. The chicken Cdh11-Intron1 genomic sequence was utilized for
luciferaseassaysand ChIP assays.Genomicalignment with zebrafish
(NW_001879268.3), frog (NW_003163392.1), dog (NW_876316.1),
human (NW_0018388290.1), monkey (NW_001111353.1),
cow (NW_001493595.2), rat (NW_001084742.1), and mouse
(NW_001030904.1) conserved sequences is shown. The dashed
boxes indicate predicted transcription factor binding sites, and the
black lines represent the location of primers used for ChIP assays.
(TIF)
Figure S3 Sema3C-Intron1 ECR cross species genomic
alignment and conserved transcription factor binding
sites. The mouse Sema3C-Intron1 genomic sequence was utilized
for luciferase assays and ChIP assays. Genomic alignment with
human (NW_001839063.1) and monkey (NW_001114280.1)
conserved sequences is shown. These sequences were not
conserved in zebrafish, frog, chicken, dog, or cow genomes. The
dashed boxes indicate predicted transcription factor binding sites,
and the black lines represent the location of primers used for ChIP
assays.
(TIF)
Figure S4 Rab39b-39UTR, and Gadd45a-prm ECR cross
species genomic alignment and conserved transcription
factor binding sites. The mouse Rab39b-39UTR (top) genomic
sequence was utilized for luciferase assays and ChIP assays.
Genomic alignment to corresponding monkey (NW_001218204.1)
and human (NW_001842420.1) conserved sequences is shown.
These sequences were not conserved in zebrafish, frog, chicken,
dog, or cow genomes. The mouse Gadd45a-prm (bottom) genomic
sequence was utilized for luciferase assays and ChIP assays.
Genomic alignment with monkey (NW_001108704.1) and human
(NW_001830579.2) sequences is shown. The dashed boxes
indicate predicted transcription factor binding sites, and the black
lines represent the location of primers used for ChIP assays.
(TIF)
Acknowledgments
The authors thank Joshua Vincentz for assistance with genomic analysis.
We also thank Jeffrey Molkentin, Yutaka Yamanaka, Anthony Firulli, and
James Martin for providing plasmids and members of the Yutzey lab for
constructive comments.
Author Contributions
Conceived and designed the experiments: MPL KEY. Performed the
experiments: MPL. Analyzed the data: MPL KEY. Contributed reagents/
materials/analysis tools: MPL KEY. Wrote the paper: MPL KEY.
References
1. Thisse B, el Messal M, Perrin-Schmitt F (1987) The twist gene: isolation of a
Drosophila zygotic gene necessary for the establishment of dorsoventral pattern.
Nucleic Acids Res 15: 3439–3453.
2. Chen ZF, Behringer RR (1995) twist is required in head mesenchyme for cranial
neural tube morphogenesis. Genes Dev 9: 686–699.
3. Firulli BA, Redick BA, Conway SJ, Firulli AB (2007) Mutations within helix I of
Twist1 result in distinct limb defects and variation of DNA binding affinities.
J Biol Chem 282: 27536–27546.
4. Chakraborty S, Wirrig EE, Hinton RB, Merrill WH, Spicer DB, et al. (2010)
Twist1 promotes heart valve cell proliferation and extracellular matrix gene
expression during development in vivo and is expressed in human diseased aortic
valves. Dev Biol 347: 167–179.
5. Ansieau S, Morel AP, Hinkal G, Bastid J, Puisieux A (2010) TWISTing an
embryonic transcription factor into an oncoprotein. Oncogene 29: 3173–3184.
6. Hinton RB, Jr., Lincoln J, Deutsch GH, Osinska H, Manning PB, et al. (2006)
Extracellular matrix remodeling and organization in developing and diseased
aortic valves. Circ Res 98: 1431–1438.
7. Shelton EL, Yutzey KE (2007) Tbx20 regulation of endocardial cushion cell
proliferation and extracellular matrix gene expression. Dev Biol 302: 376–388.
8. Shelton EL, Yutzey KE (2008) Twist1 function in endocardial cushion cell
proliferation, migration, and differentiation during heart valve development.
Dev Biol 317: 282–295.
9. Combs MD, Yutzey KE (2009) VEGF and RANKL regulation of NFATc1 in
heart valve development. Circ Res 105: 565–574.
10. Chakraborty S, Cheek J, Sakthivel B, Aronow BJ, Yutzey KE (2008) Shared
gene expression profiles in developing heart valves and osteoblast progenitor
cells. Physiol Genomics 35: 75–85.
11. Barnes RM, Firulli AB (2009) A twist of insight - the role of Twist-family bHLH
factors in development. Int J Dev Biol 53: 909–924.
12. Connerney J, Andreeva V, Leshem Y, Mercado MA, Dowell K, et al. (2008)
Twist1 homodimers enhance FGF responsiveness of the cranial sutures and
promote suture closure. Dev Biol 318: 323–334.
13. Mori M, Nakagami H, Koibuchi N, Miura K, Takami Y, et al. (2009) Zyxin
mediates actin fiber reorganization in epithelial-mesenchymal transition and
contributes to endocardial morphogenesis. Mol Biol Cell 20: 3115–3124.
14. Oshima A, Tanabe H, Yan T, Lowe GN, Glackin CA, et al. (2002) A novel
mechanism for the regulation of osteoblast differentiation: transcription of
periostin, a member of the fasciclin I family, is regulated by the bHLH
transcription factor, twist. J Cell Biochem 86: 792–804.
15. Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C, et al. (2006)
N-cadherin gene expression in prostate carcinoma is modulated by integrin-
dependent nuclear translocation of Twist1. Cancer Res 66: 3365–3369.
16. Loots GG, Ovcharenko I (2004) rVISTA 2.0: evolutionary analysis of
transcription factor binding sites. Nucleic Acids Res 32: W217–221.
17. Ho Sui SJ, Mortimer JR, Arenillas DJ, Brumm J, Walsh CJ, et al. (2005)
oPOSSUM: identification of over-represented transcription factor binding sites
in co-expressed genes. Nucleic Acids Res 33: 3154–3164.
18. Jegga AG, Sherwood SP, Carman JW, Pinski AT, Phillips JL, et al. (2002)
Detection and visualization of compositionally similar cis-regulatory element
clusters in orthologous and coordinately controlled genes. Genome Res 12:
1408–1417.
19. Gotea V, Ovcharenko I (2008) DiRE: identifying distant regulatory elements of
co-expressed genes. Nucleic Acids Res 36: W133–139.
20. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S (1983) In vitro
differentiation and calcification in a new clonal osteogenic cell line derived from
newborn mouse calvaria. J Cell Biol 96: 191–198.
21. Plageman TF, Jr., Yutzey KE (2004) Differential expression and function of
Tbx5 and Tbx20 in cardiac development. J Biol Chem 279: 19026–19034.
Twist1 Target Genes in Heart Valve Development
PLoS ONE | www.plosone.org 13 December 2011 | Volume 6 | Issue 12 | e2975822. Meyers SG, Corsi AK (2010) C. elegans twist gene expression in differentiated
cell types is controlled by autoregulation through intron elements. Dev Biol 346:
224–236.
23. Evans-Anderson HJ, Alfieri CM, Yutzey KE (2008) Regulation of cardiomy-
ocyte proliferation and myocardial growth during development by FOXO
transcription factors. Circ Res 102: 686–694.
24. Sengupta A, Molkentin JD, Yutzey KE (2009) FOXO transcription factors
promote autophagy in cardiomyocytes. J Biol Chem 284: 28319–28331.
25. Mandel EM, Kaltenbrun E, Callis TE, Zeng XX, Marques SR, et al. (2010) The
BMP pathway acts to directly regulate Tbx20 in the developing heart.
Development 137: 1919–1929.
26. Combs MD, Braitsch CM, Lange AW, James JF, Yutzey KE (2011) NFATC1
promotes epicardium-derived cell invasion into myocardium. Development 138:
1747–1757.
27. Zhou J, Rappaport EF, Tobias JW, Young TL (2006) Differential gene
expression in mouse sclera during ocular development. Invest Ophthalmol Vis
Sci 47: 1794–1802.
28. Wang X, Wang RH, Li W, Xu X, Hollander MC, et al. (2004) Genetic
interactions between Brca1 and Gadd45a in centrosome duplication, genetic
stability, and neural tube closure. J Biol Chem 279: 29606–29614.
29. Ma L, Lu MF, Schwartz RJ, Martin JF (2005) Bmp2 is essential for cardiac
cushion epithelial-mesenchymal transition and myocardial patterning. Develop-
ment 132: 5601–5611.
30. Ehrman LA, Yutzey KE (1999) Lack of regulation in the heart forming region of
avian embryos. Dev Biol 207: 163–175.
31. Lincoln J, Alfieri CM, Yutzey KE (2004) Development of heart valve leaflets and
supporting apparatus in chicken and mouse embryos. Dev Dyn 230: 239–250.
32. Martin KA, Walsh K, Mader SL (1994) The mouse creatine kinase paired E-box
element confers muscle-specific expression to a heterologous promoter. Gene
142: 275–278.
33. Bulger M, Groudine M (2010) Enhancers: the abundance and function of
regulatory sequences beyond promoters. Dev Biol 339: 250–257.
34. Connerney J, Andreeva V, Leshem Y, Muentener C, Mercado MA, et al. (2006)
Twist1 dimer selection regulates cranial suture patterning and fusion. Dev Dyn
235: 1345–1357.
35. Castanon I, Von Stetina S, Kass J, Baylies MK (2001) Dimerization partners
determine the activity of the Twist bHLH protein during Drosophila mesoderm
development. Development 128: 3145–3159.
36. Capparuccia L, Tamagnone L (2009) Semaphorin signaling in cancer cells and
in cells of the tumor microenvironment–two sides of a coin. J Cell Sci 122:
1723–1736.
37. Zhou Y, Gunput RA, Pasterkamp RJ (2008) Semaphorin signaling: progress
made and promises ahead. Trends Biochem Sci 33: 161–170.
38. Feiner L, Webber AL, Brown CB, Lu MM, Jia L, et al. (2001) Targeted
disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic
arch interruption. Development 128: 3061–3070.
39. Vincentz JW, Barnes RM, Rodgers R, Firulli BA, Conway SJ, et al. (2008) An
absence of Twist1 results in aberrant cardiac neural crest morphogenesis. Dev
Biol 320: 131–139.
40. Kawaguchi J, Kii I, Sugiyama Y, Takeshita S, Kudo A (2001) The transition of
cadherin expression in osteoblast differentiation from mesenchymal cells:
consistent expression of cadherin-11 in osteoblast lineage. J Bone Miner Res
16: 260–269.
41. Vallin J, Girault JM, Thiery JP, Broders F (1998) Xenopus cadherin-11 is
expressed in different populations of migrating neural crest cells. Mech Dev 75:
171–174.
42. Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, et al. (2008) Twist
promotes tumor cell growth through YB-1 expression. Cancer Res 68: 98–105.
43. Rosemary Siafakas A, Richardson DR (2009) Growth arrest and DNA damage-
45 alpha (GADD45alpha). Int J Biochem Cell Biol 41: 986–989.
44. Kardassis D, Murphy C, Fotsis T, Moustakas A, Stournaras C (2009) Control of
transforming growth factor beta signal transduction by small GTPases. Febs J
276: 2947–2965.
45. Hegedus Z, Czibula A, Kiss-Toth E (2007) Tribbles: a family of kinase-like
proteins with potent signalling regulatory function. Cell Signal 19: 238–250.
46. Medema JP, Schuurhuis DH, Rea D, van Tongeren J, de Jong J, et al. (2001)
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from
cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper
type 1 and type 2 cells. J Exp Med 194: 657–667.
47. Wirrig EE, Hinton RB, Yutzey KE (2011) Differential expression of cartilage
and bone-related proteins in pediatric and adult diseased aortic valves. J Mol
Cell Cardiol 50: 561–569.
48. Wirrig EE, Yutzey KE (2011) Transcriptional regulation of heart valve
development and disease. Cardiovasc Pathol 20: 162–167.
Twist1 Target Genes in Heart Valve Development
PLoS ONE | www.plosone.org 14 December 2011 | Volume 6 | Issue 12 | e29758